DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial Sponsored by Bristol-Myers Squibb and Pfizer Samuel Z. Goldhaber, MD Brigham and Womens.
Documents Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial Sponsored by Bristol-Myers...

Slide 1Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial Sponsored by Bristol-Myers Squibb and Pfizer Samuel Z. Goldhaber, MD Brigham and Womens Hospital…

Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- Expert Faculty Debate the Evidence.2014
Health & Medicine Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- Expert Faculty Debate...

1. Joseph J. Eron, Jr., MD University of North Carolina Chapel Hill, North Carolina Daniel R. Kuritzkes, MD Brigham and Women’s Hospital Harvard Medical School Boston,…

PRavastatin Or atorVastatin Evaluation and Infection Therapy (TIMI 22) Disclosure Statement: Dr. Cannon currently receives research grant support from.
Documents PRavastatin Or atorVastatin Evaluation and Infection Therapy (TIMI 22) Disclosure Statement: Dr....

Slide 1 PRavastatin Or atorVastatin Evaluation and Infection Therapy (TIMI 22) Disclosure Statement: Dr. Cannon currently receives research grant support from Bristol-Myers…

COPD and Co-morbidities: Chance or Fate? Bartolome R. Celli, MD Brigham and Women’s Hospital Harvard Medical School Boston.
Documents COPD and Co-morbidities: Chance or Fate? Bartolome R. Celli, MD Brigham and Women’s Hospital...

Slide 1 COPD and Co-morbidities: Chance or Fate? Bartolome R. Celli, MD Brigham and Women’s Hospital Harvard Medical School Boston Slide 2 Chronic Obstructive Pulmonary…

Global Trials: Challenges and Opportunities Case Study: The ExTRACT-TIMI 25 Trial Elliott Antman, MD Brigham and Women’s Hospital Harvard Medical School.
Documents Global Trials: Challenges and Opportunities Case Study: The ExTRACT-TIMI 25 Trial Elliott Antman, MD...

Slide 1 Global Trials: Challenges and Opportunities Case Study: The ExTRACT-TIMI 25 Trial Elliott Antman, MD Brigham and Women’s Hospital Harvard Medical School Boston,…

Clinical Conference Anesthesia Machines don ’ t fail, do they? James H. Philip M(E)E, MD Brigham and Women’s Hospital October 30, 2002 © Copyright 2002,
Documents Clinical Conference Anesthesia Machines don ’ t fail, do they? James H. Philip M(E)E, MD Brigham.....

Slide 1 Clinical Conference Anesthesia Machines don ’ t fail, do they? James H. Philip M(E)E, MD Brigham and Women’s Hospital October 30, 2002 © Copyright 2002, James…

Jeffrey J. Popma, MD Klaus A. Tiroch, MD Brigham and Women’s Hospital Harvard Medical School Boston, MA CYPHER™ Stent Fracture: An Uncommon Complication.
Documents Jeffrey J. Popma, MD Klaus A. Tiroch, MD Brigham and Women’s Hospital Harvard Medical School...

Slide 1 Jeffrey J. Popma, MD Klaus A. Tiroch, MD Brigham and Women’s Hospital Harvard Medical School Boston, MA CYPHER™ Stent Fracture: An Uncommon Complication after…

Living Enabled or Living Disabled: Beliefs and Choices Chris Brigham, MD Brigham and Associates.
Documents Living Enabled or Living Disabled: Beliefs and Choices Chris Brigham, MD Brigham and Associates.

Slide 1 Living Enabled or Living Disabled: Beliefs and Choices Chris Brigham, MD Brigham and Associates Slide 2 Goals Identify key questions. Contrast exceptionally abled…

Optimizing Ventricular Pacing in Sinus Node Disease Michael O. Sweeney, MD Brigham and Women’s Hospital Assistant Professor of Medicine Harvard Medical.
Documents Optimizing Ventricular Pacing in Sinus Node Disease Michael O. Sweeney, MD Brigham and Women’s...

Slide 1 Optimizing Ventricular Pacing in Sinus Node Disease Michael O. Sweeney, MD Brigham and Women’s Hospital Assistant Professor of Medicine Harvard Medical School Boston,…

PR avastatin O r ator V astatin E valuation and I nfection T herapy (TIMI 22)
Documents PR avastatin O r ator V astatin E valuation and I nfection T herapy (TIMI 22)

PRavastatin Or atorVastatin Evaluation and Infection Therapy (TIMI 22) Disclosure Statement: Dr. Cannon currently receives research grant support from Bristol-Myers Squibb,…

Popular Categories
Relevant Tags